Evidence map›Paper›PMID 27959419›Full record

ArticleMolecular medicine reports2017

Antimicrobial resistance development following surgical site infections.

Daniela Călina, Anca Oana Docea, Lucica Rosu, Ovidiu Zlatian, Alexandra Floriana Rosu, Florin Anghelina, Otilia Rogoveanu, Andreea Letiția Arsene, Alina Crenguța Nicolae, Cristina Manuela Drăgoi and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Biofertilizer microorganisms accompanying pathogenic attributes: a potential threat.Physiology and molecular biology of plants : an international journal of functional plant biology · 2022
    Review
  17. Review
  18. Prevalence and Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Daniela CălinaDepartment of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Anca Oana DoceaDepartment of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Lucica RosuDepartment of Microbiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Ovidiu ZlatianDepartment of Microbiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Alexandra Floriana RosuDepartment of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Florin AnghelinaDepartment of Otorhinolaryngology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Otilia RogoveanuDepartment of Physiotherapy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Andreea Letiția ArseneDepartment of Pharmaceutical Microbiology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Alina Crenguța NicolaeDepartment of Biochemistry, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Cristina Manuela DrăgoiDepartment of Biochemistry, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
John TsiaoussisLaboratory of Anatomy, Medical School of Heraklion, University of Crete, Heraklion 71003, Greece.
Aristides M TsatsakisLaboratory of Toxicology, Medical School, University of Crete, Heraklion 71003, Greece.
Demetrios A SpandidosLaboratory of Clinical Virology, Medical School, University of Crete, Heraklion 71003, Greece.
Nikolaos DrakoulisResearch Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens 15771, Greece.
Eliza GofitaDepartment of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
University of Medicine and Pharmacy of Craiova · ROCarol Davila University of Medicine and Pharmacy · ROUniversity of Crete · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical site infections (SSIs) determine an increase in hospitalization time and antibiotic therapy costs. The aim of this study was to identify the germs involved in SSIs in patients from the Clinical Emergency County Hospital of Craiova (SCJUC) and to assess their resistance to antimicrobials, with comparisons between surgical wards and the intensive care unit (ICU). The biological samples were subjected to classical bacteriological diagnostics. Antibiotic resistance was tested by disc diffusion. We used hierarchical clustering as a method to group the isolates based upon the antibiotic resistance profile. The most prevalent bacterial species isolated were Staphylococcus aureus (S. aureus; 50.72%), followed by Escherichia coli (E. coli; 17.22%) and Pseudomonas aeruginosa; 10.05%). In addition, at lower percentages, we isolated glucose-non-fermenting, Gram-negative bacteria and other Enterobacteriaceae. The antibiotic resistance varied greatly between species; the most resistant were the non-fermenting Gram‑negative rods. E. coli exhibited lower resistance to third generation cephalosporins, quinolones and carbapenems. By contrast, Klebsiella was resistant to many cephalosporins and penicillins, and to a certain extent to carbapenems due to carbapenemase production. The non-fermenting bacteria were highly resistant to antibiotics, but were generally sensitive to colistin. S. aureus was resistant to ceftriaxone (100%), penicillin (91.36%), amoxicillin/clavulanate (87.50%), amikacin (80.00%) and was sensitive to levofloxacin, doxycycline, gentamycin, tigecycline and teicoplanin. The Enterobacteriaceae resistance was only slightly higher in the ICU, particularly to carbapenems (imipenem, 31.20% in the ICU vs. 14.30% in the surgical wards; risk ratio = 2.182). As regards Staphylococcus species, but for non-fermenting bacteria, even if the median was almost the same, the antibiotic resistance index values were confined to the upper limit in the ICU. The data gathered from this study may help infection control teams to establish effective guidelines for antibiotic therapies in various surgical procedures, in order to minimize the risk of developing SSIs by the efficient application of the anti-infection armamentarium.

Indexed as

Drug Resistance, BacterialAdolescentAdultAgedAged, 80 and overAnti-Infective AgentsCluster AnalysisFemaleGram-Negative BacteriaGram-Positive BacteriaHumansIntensive Care UnitsMaleMiddle AgedSurgical Wound InfectionYoung AdultAnti-Infective Agents

Identifiers

PMID27959419
PMCPMC5364857
OpenAlexW2566832358

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.